Entero Therapeutics, Inc. - Common stock, par value $0.0001 per share (ENTO) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2023 to Q3 2025

Type / Class
Equity / Common stock, par value $0.0001 per share
Symbol
ENTO on Nasdaq
Shares outstanding
4,712,245
Price per share
$0.60
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
0
Total reported value
$0
Share change
-118,946
Value change
-$47,579
Number of holders
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Entero Therapeutics, Inc. - Common stock, par value $0.0001 per share (ENTO) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Ali Arif Nasir 4.9% -8% $92,360 -$8,000 230,900 -8% Ali Arif Nasir 06 Jun 2025

As of 30 Sep 2025, 0 institutional investors reported holding 0 shares of Entero Therapeutics, Inc. - Common stock, par value $0.0001 per share (ENTO). This represents 0% of the company’s total 4,712,245 outstanding shares.

Institutional Holders of Entero Therapeutics, Inc. - Common stock, par value $0.0001 per share (ENTO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 0 $0 -$47,579 $0.60 0
2025 Q2 118,946 $47,579 -$11,403 $0.40 9
2025 Q1 141,553 $67,222 +$27,272 $0.48 7
2024 Q4 72,212 $44,916 -$2,913 $0.62 9
2024 Q3 93,384 $32,071 +$24,613 $0.34 7
2024 Q2 21,630 $27,088 +$10,463 $1.00 5
2024 Q1 40,255 $177,075 +$158,165 $4.38 6
2023 Q4 4,381 $18,399 +$18,399 $4.17 5